Get started
Author

Fangfang Liu

SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer
2026 · Lei Wang, Han Chu, et al. · Nature Cell Biology · 15
HE4 drives PD-L1 expression in myeloid cells via IFN-γR-JAK-STAT3 signaling to promote tumor immune evasion
2026 · Bo Zeng, Yingying Zhou, et al. · Cell Reports Medicine · 1
Cellular senescence in lung cancer immune microenvironment and senotherapeutic opportunities
2026 · Zhaolin Xu, Fangfang Liu, et al. · iScience · 1
Glycolytic reprogramming in cancer: tumour cell metabolism, immune modulation, and therapeutic opportunities
2026 · Lei Wang, Fangfang Liu, et al. · Journal of Translational Medicine
Peripheral blood IFN-γ–producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor–based therapy
2026 · Chengyan Wang, Fangfang Liu, et al. · Discover Oncology
Durvalumab plus chemotherapy prior to chemoradiotherapy and followed by durvalumab as consolidation for patients with limited-stage small cell lung cancer (CONCUR study).
2026 · Qian Chu, Shanshan Huang, et al. · Journal of Clinical Oncology
Nuclear expression of AIRE in lung squamous cell carcinoma correlates with immune microenvironment remodeling and poor prognosis
2026 · Chengyan Wang, Chuhuai Wang, et al. · Tumori Journal
Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer
2026 · Lei Wang, Han Chu, et al. · Nature Cell Biology
PDF
Works count: 8
Citation count: 17
H-index: 1
I10-index: 1
Year
Topic
Type